Literature DB >> 35221440

Antimalarial drug resistance in tropical countries: a solution towards decreasing mortality of children under 5 years of age.

Idris Zubairu Sadiq1.   

Abstract

Entities:  

Year:  2021        PMID： 35221440      PMCID： PMC8879351          DOI： 10.24911/SJP.106-1617926256

Source DB:  PubMed          Journal:  Sudan J Paediatr        ISSN： 0256-4408


× No keyword cloud information.
  10 in total

1.  Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum.

Authors:  M B Reed; K J Saliba; S R Caruana; K Kirk; A F Cowman
Journal:  Nature       Date:  2000-02-24       Impact factor: 49.962

2.  The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin.

Authors:  M T Duraisingh; P Jones; I Sambou; L von Seidlein; M Pinder; D C Warhurst
Journal:  Mol Biochem Parasitol       Date:  2000-04-30       Impact factor: 1.759

3.  Artemisinin Resistance in Southeast Asia.

Authors:  Steve Meshnick
Journal:  Clin Infect Dis       Date:  2016-08-23       Impact factor: 9.079

4.  Knowing the enemy: genetics to track antimalarial resistance.

Authors:  Didier Ménard; Alfredo Mayor
Journal:  Lancet Infect Dis       Date:  2020-07-14       Impact factor: 25.071

5.  Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum.

Authors:  M T Duraisingh; C Roper; D Walliker; D C Warhurst
Journal:  Mol Microbiol       Date:  2000-05       Impact factor: 3.501

6.  In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.

Authors:  Leah Mwai; Steven M Kiara; Abdi Abdirahman; Lewa Pole; Anja Rippert; Abdi Diriye; Pete Bull; Kevin Marsh; Steffen Borrmann; Alexis Nzila
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

7.  Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children.

Authors:  Patrick Tumwebaze; Melissa D Conrad; Andrew Walakira; Norbert LeClair; Oswald Byaruhanga; Christine Nakazibwe; Benjamin Kozak; Jessica Bloome; Jaffer Okiring; Abel Kakuru; Victor Bigira; James Kapisi; Jennifer Legac; Jiri Gut; Roland A Cooper; Moses R Kamya; Diane V Havlir; Grant Dorsey; Bryan Greenhouse; Samuel L Nsobya; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

8.  Severe Malaria in African Children - The Need for Continuing Investment.

Authors:  Kathryn Maitland
Journal:  N Engl J Med       Date:  2016-12-22       Impact factor: 91.245

9.  Molecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria.

Authors:  Christian N Nguetse; Ayola Akim Adegnika; Tsiri Agbenyega; Bernhards R Ogutu; Sanjeev Krishna; Peter G Kremsner; Thirumalaisamy P Velavan
Journal:  Malar J       Date:  2017-05-23       Impact factor: 2.979

10.  Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms.

Authors:  Maja Malmberg; Pedro E Ferreira; Joel Tarning; Johan Ursing; Billy Ngasala; Anders Björkman; Andreas Mårtensson; José P Gil
Journal:  J Infect Dis       Date:  2012-12-05       Impact factor: 5.226
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.